Tag Archive: PharmaCann
Cannabis Briefs for November 5, 2024
•The rescheduling of cannabis from Schedule I to Schedule III in the U.S. has been further delayed, with an administrative law judge calling for more detailed information and to set a hearing date for January or February of 2025. Continue reading →
Multi-State Players Curaleaf, PharmaCann Target Growth In New York
After a slow launch, hamstrung by licensing delays and lawsuits, New York’s adult-use cannabis market is seeing investment from multi-state operators, with billion-dollar player Curaleaf as well as PharmaCann both entering the adult-use market and telling SNDC they see opportunity ahead. Continue reading →
Posted in News on January 30, 2024New York Aims To Have 37 Dispensaries Open By Year-End
While New York’s cannabis market has been plagued by a slow retail rollout, the Empire State is now looking to ramp up licensing and open as many as a dozen new stores by the end of the year, reaching a total of 37 dispensaries statewide. Continue reading →
Posted in News on December 19, 2023Cannabis Briefs for October 19, 2021
•In case you missed last Thursday’s news alert, Canadian cannabis giant Canopy Growth has agreed to acquire leading U.S. edibles maker Wana Brands for $297.5 million, pending federal legalization. Continue reading →
Posted in News on October 19, 2021Key Players Talk Trends In The Surging Illinois Cannabis Market
After revenues passed the $1 billion mark in its first year of adult-use sales, the Illinois cannabis market is primed for further expansion this year. Continue reading →
Posted in News on February 2, 2021From Zero To $1 Billion: Illinois Adult-Use Market Booms In First Year
In its first year of adult-use legalization, Illinois raked in overall marijuana sales of more than $1 billion, according to the Illinois Department of Financial and Professional Regulation (IDFPR). Continue reading →
Posted in News on January 26, 2021
